Bayer announces new Analysis of Vitrakvi (R) (Larotrectinib) for Patients with gastrointestinal TRK Fusion Tumors

[Anonymous]

VISCERAL MEDICINE, 2020; 36 (2): 152

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索